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ABSTRACT
Enterococci, especially Enterococcus faecalis and faecium, have emerged as an important nosocomial pathogen and represent a serious 
threat to patients with impaired host defenses. E. faecalis and faecium are part of the normal intestinal microbial flora of poultry and 
man under most conditions, they are considered as an opportunistic pathogen. In the current study, an investigation of Enterococcus spp. 
isolated from poultry feces and their antibiotic susceptibility pattern was studied, due to the worldwide attachment with poultry by 
human being. Samples were collected from different sites of Allahabad, India, 80 samples collected screened for the presence of E. faecalis 
and E. faecium and identified based on cultural and biochemical characteristics. Thirty-five isolates were identified as E. faecalis (57.37%), 
while 26 were E. faecium (42.62%). The pathogens isolated were tested for their susceptibility toward 10 different commonly prescribed 
antibiotics. Most of the isolates showed resistance toward antibiotics under study. E. faecalis strain suggested a higher percentage of 
possibility of infection estimated by 15% in comparison with E. faecium as it was found to be less in a screening. The high resistance rate 
also indicates the negative impact of the antibiotic therapy. To evaluate the extent of transmission and impact of such transmission on the 
effectiveness of the antibacterial use in human medicine, further study is imperative. Periodic monitoring of antibiotic resistance pattern 
to detect any change in it would be necessary for the effective treatment against these pathogens. Enterococci revealed an alarming rate 
of resistance to the standard antimicrobial agents used for therapy and raised MIC values to vancomycin. The importance and infection 
control were stressed.
Keywords: Enterococcus faecalis, Enterococcus faecium, poultry feces, vancomycin resistance
INTRODUCTION
Enterococci are members of the normal intestinal microflora in humans and animals, and they are common in environments affected by animal and human 
fecal material. These organisms are not considered primary 
pathogens, but due to their ability to acquire high-level 
resistance to antimicrobial agents, enterococci have emerged 
as nosocomial pathogens worldwide.[1] Concern has especially 
been focused on enterococci that show high-level resistance to 
the glycopeptide antibiotic vancomycin (vancomycin-resistant 
enterococci) (VRE), which recently has been the drug of the 
last resort against multiresistant enterococci and methicillin-
resistant Staphylococcus aureus.[2]
Genetical similarities between animal and human 
originated enterococci have been reported and role of 
natural transmission of enterococci from food animals and 
contaminated foods to human tract cannot be ruled out.[3] 
Enterococci cause food intoxication through the production of 
biogenic amines and worrisome opportunistic infections due 
to the virulence traits.[4] Some strains are resistant to many 
antibiotics, but antibiotic resistance alone cannot explain the 
virulence of enterococci.[3] The differentiation of apparently 
safe and non-safe enterococci strains is not simple, especially 
due to effective horizontal gene transfer mechanisms.[5] 
Enterococcus faecalis and Enterococcus faecium are the most 
relevant species of Enterococcus genus with regard to clinical 
aspects.[6]
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Vancomycin as a definition is an antibiotic at the end of the 
last resort for the treatment of Gram-positive microorganisms 
such as MRSA and the multidrug-resistant Staphylococcus 
epidermidis [Figure 1].[7-10]
In addition to the emergence of VRE,[11] clinical isolates of 
MRSA strains with decreased susceptibility to vancomycin[12] 
(vancomycin intermediate-resistant S. aureus) and more 
recently with high-level vancomycin resistance [Figure 1].[13]
Avoparcin is a glycopeptide antibiotic that has been used as 
a growth-promoting agent for food animals in many countries, 
except the United States and Canada. In human medicine, 
glycopeptide-resistant enterococci (GRE) have become an 
increasingly serious problem in the treatment of nosocomial 
infections.[14] In Europe, GRE have been isolated from animals, 
meat, environment, and healthy humans outside hospitals.[15-17]
The widespread use of glycopeptides in hospitals has led 
to the emergence of VRE which is a major concern for health-
care professionals. VRE is frequently reported from hospitals 
in the USA and Europe.[19] There is a paucity of information 
on vancomycin resistance in enterococci from our country.[20] 
Since chicken meat and products are highly consumed by 
human beings and influx of virulence genes from enterococci 
of chicken origin to human intestinal tract is a possible route; 
therefore, it is desirable to study the antibiotic susceptibility 
pattern of Enterococcus spp. to ensure the safe consumption of 
chicken and their products.[21] In this study, the incidence of 
Enterococcus spp. has been isolated, identified, and tested for 
their antibiotic susceptibility pattern.
MATERIALS AND METHODS
Sample Collection
Fresh poultry fecal samples were collected from (Mahewa Purab 
Patti, Naini, Atala, and Civil Lines) Allahabad, India, and used 
in the present study. A total of 80 fecal samples (20 from each 
site) were collected in pre-autoclaved glass sample bottles and 
immediately transported to the laboratory for further studies.
Isolation of Enterococcus spp.
About 0.5 g of each fecal sample was diluted in 4.5 ml of sterile 
physiological water and roughly homogenized. Serial dilutions 
ranking from 10−3 to 10−7 prepared. Afterward, 100 µL of each 
dilution has been plated in duplicate into a Bile Esculin Azide Agar 
(BEA) medium and incubated for 24–48 h at 30°C, pH 7.1 ± 0.2. 
The isolates identified using standard morphological, cultural, 
and biochemical tests.[22]  After incubation time, samples were 
inspected, and those containing from 50 to 100 colonies were 
selected for preliminary identification based on morphological 
and physical characteristics like Gram staining and production 
of catalase, oxidase, and acid from glucose fermentation.
Morphological Characteristics
Various cultural and morphological characteristics of the 
isolates have been examined, namely, color, elevation, odor, 
and surface of the colonies on BEA agar plates.
Biochemical Tests
Slide catalase test
A glass rod has been used to pick up a colony from a culture plate 
and has been placed in a drop of 3% hydrogen peroxide on a 
glass slide. A positive catalase reaction would show gas bubbles.
Nitrate Reduction Test
This test has been used to identify whether an organism 
that was able to reduce nitrate into nitrite and further into 
ammonia or molecular nitrogen. The isolates have been 
inoculated into nitrate broth media and incubated at 37 ± 2°C 
for 24 h. Nitrate reagent (Solution A) sulfanilic acid + acetic 
acid and Solution B – α-naphthylamine + acetic acid added to 
observe the color change into red indicate positive result.
Sugar fermentation test
This test has been performed to determine the ability of 
Enterococcus spp. to ferment various carbohydrates under 
anaerobic condition in fermentation tube. For this purpose, 
basal media have been prepared and 4.5 ml of this media have 
been transferred into test tube along with inverted Durham’s 
tubes and autoclaved at 121°C for 15–20 min. Different 
carbohydrates, namely, glucose, lactose, galactose, mannitol, 
sorbitol, sucrose, maltose, xylose, and dextrose have been 
prepared in 1% concentration in distilled water and autoclaved 
at 10 lbs/inch² separately. Then, 0.5 ml aliquot from sterile 
Figure 1: (a) Structure of vancomycin 1 and a binding scheme 
between vancomycin and a cell wall precursor analog, DADA. (b) A 
cartoon illustration of the type of Click vancomycin dimers[18]
a
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stock solution of each sugar added in 4.5 ml of basal medium. 
One loopful of isolated strains inoculated in each sugar solution 
and incubated at 37°C for 24–48 h. After incubation, the tubes 
have been observed for color change and gas production. 
Uninoculated tube period has been taken as control.
Starch Hydrolysis Test
Starch agar media were prepared and autoclaved at 121°C 
for 15–20 min. Then, the plates have been streaked with 
the bacterial isolates and incubated at 37°C for 24 h. After 
incubation period, the plates flooded with iodine solution 
(1 M) and observed for clear zone around the colonies. 
Formation of clear zone around the colonies indicates positive 
starch hydrolysis.
Motility Test
This test has been done to check the motility of the bacteria. 
Tube containing motility agar has been stab inoculated and 
incubated at 37°C for 24 h. Growth around the stab line 
indicates a positive test. No growth around the stab line 
indicates a negative test.
Indole Production Test
Test tubes containing peptone broth will be inoculated with 
test organism and incubated at 37°C + 1°C for 24–48 h. After 
incubation, the 10 drops of Kovac’s reagent will be added to 
it. A red color ring on the top of the peptone water indicated 
positive result.
Growth at various temperatures
The isolates have been streaked on the BEA agar plates and 
incubated at three different incubation temperatures, i.e., 10, 
45, and 50°C for 24 h. After incubation period, the plates have 
been observed for microbial growth.
Study of antibiotic susceptibility pattern of identified bacterial 
isolates
The antibiotic susceptibility of the isolated and identified 
Enterococcus species has been assessed by the disc diffusion 
method.[23] For this test, melted and cooled Muller-Hinton 
agar has been poured in sterilized Petri dishes and swabbed 
with overnight culture of Enterococcus isolates. Under aseptic 
conditions, antibiotics placed onto the surface of inoculated 
plates. Following overnight incubation at 37°C, zone of 
inhibition for each antibiotic measured (in mm).
To determine the susceptibility pattern of isolated 
Enterococcus spp., the following antibiotics were used which 
are as follows: Chloramphenicol (30 µg), penicillin G (10 µg), 
erythromycin (15 µg), vancomycin (30 µg), teicoplanin 
(30 µ), ciprofloxacin (5 µg), gentamycin (10 µg), streptomycin 
(10 µg), ampicillin (10 µg), and tetracycline (30 µg).
RESULTS AND DISCUSSION
Incidence of Enterococcus spp. isolated 
from Different Sites in Allahabad City
In the present study, among 80 samples collected from 
poultry feces of Allahabad region, 61 bacterial isolates were 
obtained, of which 35 were identified as E. faecalis (57.38%) 
and 26 were E. faecium (42.62%) [Figure 2]. The percentage 
incidence of Enterococcus spp. was, however, found to be 
observed that there is a significant difference in primary 
screening of E. faecalis strain, suggesting a higher percentage 
of possibility of infection estimated by 15% in comparison with 
E. faecium as it was found to be less in a screening, isolation, 
and most importantly the pathogenicity of it at their level of 
opportunistic pattern in contrast with E. faecalis. Among both 
E. faecium and E. faecalis, some strains produced β-hemolysin 
with the incidence of this trait being higher for E. faecalis 
strains (21.3%) than for E. faecium strains (8.3%). Hemolysin 
plays an important role in enterococcal virulence, as it may 
increase the severity of the infection [Table 1].[24]
The identification of enterococci isolated from the 
commercial poultry production environment did not reveal 
any unusual species, although eight isolates require more 
discriminate analysis before definitive identification. While 
multiple isolates were occasionally recovered from the same 
sample, the elimination of isolates with indistinguishable 
antibiograms from the same farm provided a collection that 
was conservative in its estimation of diversity but did not 
substantively affect the relative proportions of species isolated.
Antibiotic Susceptibility Pattern
The antimicrobial susceptibility test was performed by disc 
diffusion method or Kirby–Bauer technique.[23] E. faecalis was 
tested for their sensitivity against various antibiotics. Most of 
the antibiotics were found to be sensitive, vancomycin (30 µg) 
was resistance (10%), and some of them were found to be 
intermediately resistance against E. faecalis [Table 2].
E. faecalis was found to be sensitive to five antibiotics, 
namely, penicillin G (10 µg), erythromycin (15 µg), ciprofloxacin 
(5 µg), streptomycin (10 µg), and tetracycline (30 µg), (50%). 
It was found to be resistant to vancomycin (30 µg) (10%). It 
was found to be intermediately resistant to gentamycin (10 µg), 
ampicillin (30 µg), teicoplanin (10 µg), and chloramphenicol 
(30 µg) (40%) [Figure 3]. Among the antibiotics, vancomycin, 
an inhibitor of cell wall synthesis is of major concern as it is 
one of the last antibiotics broadly effective against clinical 
infections caused by multidrug resistance pathogens.[25]
E. faecium was found to be sensitive to penicillin G (10 µg), 
ciprofloxacin (5 µg), and tetracycline (30 µg), and it was resistant 
vancomycin (30 µg) and streptomycin (10 µg). Furthermore, it 
was found to be intermediately resistant to chloramphenicol 
61
35
26
Total Isolates
E. faecalis (57.37%)
E. faecium (42.62)
Figure 2: Incidence of Enterococcus spp. percentages isolated from 
different sites of Allahabad city
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Table 1: Morphological characteristics and biochemical tests of 
Enterococcus spp.
Parameter Enterococcus spp.
E. faecalis E. faecium
Cultural characteristics Entire, flat, 
non-mucoid, white
Transparent, 
elevated, smooth, 
and entire margin
Gram reaction +ve +ve
Shape Cocci Cocci
Arrangement Monococci Monococci
Growth at
10°C
40°C
50°C
+ve +ve
Growth at pH 9.6 +ve +ve
Biochemical tests
Nitrate residuals +ve +ve
Catalase +ve +ve
Starch hydrolysis −ve −ve
Indole test −ve −ve
Motility −ve −ve
Esculin hydrolysis +ve −ve
Sugar fermentation
Glucose A+G− A−G−
Lactose A−G− A−G−
Maltose A−G− A−G−
Sucrose A−G− A−G−
Mannitol A+G− A−G−
Galactose A−G− A−G−
Dextrose A+G− A+G−
Sorbitol A−G− A−G−
Xylose A+G− A+G−
A+: Acid positive, A−: Acid negative, G+: Gas positive, G−: Gas negative, 
E. faecalis: Enterococcus faecalis, E. faecium: Enterococcus faecium
Table 2: Antibiotic susceptibility pattern
Antibiotics Enterococcus spp. clear 
zone (mm)
E. faecalis E. faecium
Chloramphenicol (30 µg) 15 ++ 12 ++
Penicillin G (10 µg) 26 +++ 19 +++
Erythromycin (15 µg) 24 +++ 17 ++
Vancomycin (30 µg) 10 + 10 +
Teicoplanin (30 µg) 12 ++ 17 ++
Ciprofloxacin (5 µg) 21 +++ 21 +++
Gentamycin (10 µg) 12 ++ 12 ++
Streptomycin (10 µg) 18 +++ 10 +
Ampicillin (10 µg) 15 ++ 15 ++
Tetracycline (30 µg) 23 +++ 24 +++
+++: Sensitive, ++: Intermediate, +: Resistant. Degree of inhibition 
= +: Moderate inhibition zone (6–9 mm), ++: Strong inhibition 
zone (10–14 mm) +++: Very strong inhibition zone (15–18 mm or 
above), –: No inhibition zone, E. faecalis: Enterococcus faecalis, E. faecium: 
Enterococcus faecium
(30 µg), ampicillin (30 µg), teicoplanin (10 µg), gentamycin 
(10 µg), and erythromycin (15 µg) [Table 2]. Conjugal transfer 
of vancomycin resistance genes from enterococci to other Gram-
positive bacteria has been accomplished in vitro [Figure 4]. 
The Gram-positive organisms include Group A and viridans 
group streptococci, Listeria monocytogenes, and Staphylococcus 
aureus.[26] This gives rise to concern that such transfer in humans 
under natural conditions might be feasible.
Ten (20.8%) E. faecium strains and 6 (12.8%) E. faecalis 
strains were susceptible to all antibiotics tested. All E. faecalis 
strains and all but one E. faecium strain were susceptible 
to vancomycin. E. faecium strains were mostly resistant 
to vancomycin (30 µg) (2.1%) and streptomycin (4.2%). 
While ciprofloxacin (56.3%), followed by penicillin (45.8%), 
erythromycin (27.1%), chloramphenicol (10.4%), tetracycline 
(6.3%), and gentamicin (2.1%) showed both intermediate and 
sensitive activity and none were resistant against ampicillin 
[Table 2]. In contrast, E. faecalis strains were mostly resistant to 
Figure 3: Antibiotic susceptibility pattern of Enterococcus faecalis 
isolates
Figure 4: Antibiotic susceptibility pattern of Enterococcus faecium 
isolates
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vancomycin (30 µg) (2.1%) while chloramphenicol (63.8%), 
followed by streptomycin (46.8%), tetracycline (44.7%), 
erythromycin (31.9%), ciprofloxacin (27.7%), gentamicin 
(25.5%), penicillin (12.8%), and ampicillin (2.1%) were 
found to be intermediate and sensitive.
The present results of thesis study showed that a larger 
number of E. faecium strains than E. faecalis strains were resistant 
to vancomycin, which may be explained by E. faecium being 
generally more resistant to vancomycin than E. faecalis. The 
incidence of streptomycin and vancomycin resistance for both 
E. faecium and E. faecalis was low, indicating that most of the 
strains tested did not acquire resistance determinants for these 
antibiotics. In a study of European cheeses, Teuber (1999)[27] also 
reported a low (4%) incidence of VRE. While the incidence of 
aminoglycoside-resistant enterococci was low among E. faecalis 
isolates, it was considerably higher for E. faecium. These 
results indicate that especially E. faecium strains with acquired, 
high-level aminoglycoside resistance can occur in traditional 
cheeses.[28] Frank (1996)[29] reported that isolates were found in 
36 poultry flocks and 10 pig herds and among two of the human 
isolates, whereas no vancomycin-resistant E. faecium isolates 
were found among the isolates from calves.
The pathogens isolated were tested for their susceptibility 
toward commonly prescribed antibiotics, namely, 
chloramphenicol, penicillin G, erythromycin, vancomycin, 
teicoplanin, ciprofloxacin, gentamycin, streptomycin, 
ampicillin, and tetracycline. From the present study, the 
following observations were made in incidence of E. faecalis 
in poultry feces samples which were maximum (57.37%) 
and minimum in E. faecium (42.62%). Most of the isolates 
showed resistance toward a few of antibiotics, suggesting that 
vancomycin (30 µg) (2.1%) and streptomycin (4.2%) cannot 
be used against E. faecium and E. faecalis. The high resistance 
rate also indicates the negative impact of the antibiotic therapy. 
To evaluate the extent of transmission and impact of such 
transmission on the effectiveness of the antibacterial use in 
human medicine, further study is required. Periodic monitoring 
of antibiotic resistance pattern to detect any change in it 
would be necessary for the effective treatment against these 
pathogens. The presence of high-level resistance to vancomycin 
eliminates a valuable therapeutic option in the management 
of serious enterococcal infections. Resistance to glycopeptides 
in these organisms is caused by synthesis of modified bacterial 
cell wall precursors that demonstrate decreased affinity for 
vancomycin and teicoplanin.[30] Enterococci revealed an 
alarming rate of resistance to the standard antimicrobial agents 
used for therapy and raised MIC values to vancomycin. The 
importance and infection control are stressed.
CONCLUSION
The total isolates of E. faecium and E. faecalis were found to 
be resistant to vancomycin E. faecium. Vancomycin-resistant 
E. faecalis isolates were detected only among isolates from 
four poultry flocks. The results of this study illustrate that 
Enterococcus spp. from poultry production and processing 
operations are frequently resistant to multiple antimicrobials 
and that some of these patterns may very well reflect the use of 
approved antimicrobials in poultry. This work also establishes 
a baseline of resistance among Enterococcus spp. that will be 
useful in monitoring the dynamics of resistance longitudinally. 
Considering some of the current estimates of the extent of 
antimicrobial use in the poultry production industry for growth 
enhancement, the increasing potential of such an intensive 
agricultural operation to affect antimicrobial resistance must 
be weighed against the reasonable risk that the treatment of 
human bacterial infections may be compromised.
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